bioAffinity Technologies, Inc. (BIAFW)

NASDAQ: BIAFW · Real-Time Price · USD · Warrants
0.1995
-0.0256 (-11.37%)
Jun 27, 2025, 9:35 AM - Market open
-11.37%
Market Cap 9.91M
Revenue (ttm) 8.81M
Net Income (ttm) -9.74M
Shares Out 26.82M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,505
Open 0.2220
Previous Close 0.2251
Day's Range 0.1840 - 0.2220
52-Week Range 0.1020 - 2.9000
Beta 2.56
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About BIAFW

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have... [Read more]

Sector Healthcare
Founded 2014
Employees 57
Stock Exchange NASDAQ
Ticker Symbol BIAFW
Full Company Profile

News

There is no news available yet.